EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Engineering myeloid cells for cancer immunotherapy

Jianzhu Chen, Yingjie Zhao, Xiaotong Chen, Jiayao Yan, Fuguo Liu, Rizwan Romee

Cancer Cell · 2025

DOI: 10.1016/j.ccell.2025.06.014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Cell, 2025. Verfasst von Jianzhu Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic addre…. Hauptthemen laut MEDLINE: Neoplasms, Myeloid Cells, Receptors, Chimeric Antigen, Immunotherapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Leukemia and Lymphoma Society of Canada, Leukemia and Lymphoma Society, Massachusetts Institute of Technology Koch Institute for Integrative Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMyeloid CellsReceptors, Chimeric AntigenImmunotherapyImmunotherapy, AdoptiveMacrophagesCell EngineeringHumansTumor MicroenvironmentAnimalsT-Lymphocytes

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address: jchen@mit.edu.
  • Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harv…
  • Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Förderung

  • Leukemia and Lymphoma Society of Canada
  • Leukemia and Lymphoma Society
  • Massachusetts Institute of Technology Koch Institute for Integrative Cancer Research
  • Parker Institute for Cancer Immunotherapy
  • National Cancer Institute

Zitieren

APA

Chen, J., Zhao, Y., Chen, X., Yan, J., Liu, F., & Romee, R. (2025). Engineering myeloid cells for cancer immunotherapy. Cancer Cell. https://doi.org/10.1016/j.ccell.2025.06.014

Vancouver

Chen J, Zhao Y, Chen X, Yan J, Liu F, Romee R. Engineering myeloid cells for cancer immunotherapy. Cancer Cell. 2025. doi:10.1016/j.ccell.2025.06.014

BibTeX
@article{Chen2025,
  author = {Chen, Jianzhu and Zhao, Yingjie and Chen, Xiaotong and Yan, Jiayao and Liu, Fuguo and Romee, Rizwan},
  title = {Engineering myeloid cells for cancer immunotherapy},
  journal = {Cancer Cell},
  year = {2025},
  doi = {10.1016/j.ccell.2025.06.014}
}
Kostenlos starten →